Non-Invasive Prenatal Test

 EDGC’s exclusive NIPT test, NICE®, detects trisomy 21, 18, 13 and 4 sex chromosome aneuploidy in maternal blood. Using fetal cell-free DNA and NGS (next-generation sequencing), EDGC provides more accurate analysis as to NIPT service with 99% detection rate. EDGC became the first company in Korea that included trisomy 9, 16, 22 which detects chromosome aneuploidy. We are committed to provide further test such as amniocentesis only if the NICE® test result is positive. Upon request, test for AFP (alpha-fetoprotein) is available.